Mechanisms and Outcomes in Subarachnoid Hemorrhage

Subarachnoid haemorrhage arises chiefly from the rupture of an intracranial aneurysm, releasing arterial blood into the subarachnoid space and precipitating a cascade of pathophysiological events. The initial extravasation elevates intracranial pressure, disrupts the blood–brain barrier and triggers early brain injury, which encompasses neuronal apoptosis, oxidative stress and an inflammatory response mediated by microglia and cytokine release. Subsequent breakdown of erythrocytes liberates haemoglobin and heme, which amplify vasoconstriction, endothelial dysfunction and microthrombosis. These processes underpin delayed cerebral ischaemia, a leading cause of secondary morbidity, and are modulated by impaired autoregulation and cortical spreading depolarisations. The interplay of these mechanisms determines clinical outcomes, ranging from cognitive deficits and hydrocephalus to long‐term disability and mortality. Advances in neuroimaging, multimodal monitoring and targeted interventions have begun to attenuate these sequelae, yet global disparities in access to specialised care continue to influence prognosis.

Research from Nature Portfolio

Recent studies have underscored the value of comprehensive, multidisciplinary protocols in improving survival and neurological outcomes. Advances in high‐resolution imaging, including perfusion computed tomography and transcranial Doppler ultrasonography, now allow clinicians to monitor cerebral perfusion in real‐time, guiding individualised hypertensive and endovascular therapies to avert delayed ischaemia. Progress in aneurysm securement through coils and flow‐diverting stents has reduced rebleeding risk, while neurocritical care strategies emphasise meticulous regulation of fluid balance, electrolyte homeostasis and ventilation to prevent secondary organ complications. Attention has also turned to telemedicine and digital platforms to address global disparities in access to specialised care. These integrated approaches have contributed to a measurable decline in mortality, even as the field calls for large‐scale trials to harmonise treatment protocols.

Mechanisms and Outcomes in Subarachnoid Hemorrhage publication trend

The graph below shows the total number of articles in mechanisms and outcomes in subarachnoid hemorrhage across all publications each year (not limited to Nature Index journals).

Technical terms

Early brain injury: Pathophysiological changes occurring within the first 72 hours after subarachnoid haemorrhage, encompassing intracranial pressure elevation, neuronal apoptosis and blood–brain barrier disruption.

Delayed cerebral ischaemia: Secondary reduction in cerebral blood flow occurring days after the initial haemorrhage, often associated with vasospasm and microvascular dysfunction.

Efferocytosis: Clearance of apoptotic cells, such as extravasated erythrocytes, by specialised phagocytic pathways in the meninges.

Aggregation‐induced emission (AIE): A photophysical phenomenon where non‐emissive molecules in solution become fluorescent upon aggregation, exploited in imaging probes.

Exosomes: Nano‐sized vesicles secreted by cells that carry microRNAs and proteins, used in experimental therapies to modulate intercellular signalling.

Pyroptosis: A form of programmed cell death characterised by inflammatory caspase activation and membrane pore formation, implicated in microglial injury.

References

1. Effectiveness of Lumbar Cerebrospinal Fluid Drain Among Patients With Aneurysmal Subarachnoid Hemorrhage. JAMA Neurology (2023).
2. Diagnosis and management of subarachnoid haemorrhage. Nature Communications (2024).
3. A Blood‐Responsive AIE Bioprobe for the Ultrasensitive Detection and Assessment of Subarachnoid Hemorrhage. Advanced Science (2023).
4. Dental pulp mesenchymal stem cell-derived exosomes inhibit neuroinflammation and microglial pyroptosis in subarachnoid hemorrhage via the miRNA-197-3p/FOXO3 axis. Journal of Nanobiotechnology (2024).
5. Early Brain Injury After Poor-Grade Subarachnoid Hemorrhage. Current Neurology and Neuroscience Reports (2019).
6. Management of delayed cerebral ischemia after subarachnoid hemorrhage. Critical Care (2016).